Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Efficacy of LCAR-T2C CAR-T cells
Nanjing Legend Biotech Co.
CD4+ T Lymphocyte Tumor (T Cell Lymphoma and T Cell Leukemia)
1 trial -
Efficacy of LCAR-T2C CAR-T cells
Nanjing Legend Biotech Co.
T Cell Lymphoma
1 trial -
Elagolix
NEUROCRINE BIOSCIENCES INC
Folliculogenesis
1 trial -
Empagliflozin 10 MG Oral Tablet [Jardiance]
BRIGHT MINDS BIOSCIENCES INC.
Diabetes Mellitus
1 trial -
Epidiolex
BRIGHT MINDS BIOSCIENCES INC.
CBD
1 trial -
Erythromycin lactobionate
ADIAL PHARMACEUTICALS, INC.
Diabetes Mellitus, Type 1
1 trial -
Etrumadenant
Arcus Biosciences
Healthy Participants
2 trials -
Etrumadenant
Arcus Biosciences
TNBC - Triple-Negative Breast Cancer
1 trial -
Etrumadenant
Arcus Biosciences
Non-small Cell Lung Cancer
1 trial -
Etrumadenant
Arcus Biosciences
Non Small Cell Lung Cancer Metastatic
1 trial -
Evaluate the effects of Environmental Enrichment (EE) on alcohol consumption
BRIGHT MINDS BIOSCIENCES INC.
Alcohol Use Disorder
1 trial -
Evaluating Bioequivalence of a Fixed Dose Combination versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorvastatin.
Daiichi Sankyo
No medical condition.
1 trial -
Evaluating Bioequivalence of a Fixed Dose Combination versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin.
Daiichi Sankyo
No medical condition.
1 trial -
Evaluating Bioequivalence of a Fixed Dose Combination versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Rosuvastatin.
Daiichi Sankyo
No medical condition
1 trial -
Evaluating Bioequivalence of a Fixed Dose Combination versus Tablets of Bempedoic Acid / Ezetimibe and Rosuvastatin.
Daiichi Sankyo
No medical condition.
1 trial -
Evaluation of bioequivalence of two products containing 400 mg ibuprofen and 100 mg caffeine: Ibuprofen / Caffeine 400 mg / 100 mg coated granules (Test) vs. Thomapyrin TENSION DUO, 400mg / 100mg Filmtabletten (Reference). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy volunteers
Lacuna Pharma Pty Ltd
No therapeutic indication in the current trial with healthy volunteers.
1 trial -
Evaluation of bioequivalence of two products containing 50 mg dimenhydrinate: Dimenhydrinate 50 mg (Test) vs. Vomex A 50 mg Lösung zum Einnehmen im Beutel (Comparator). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy volunteers
Lacuna Pharma Pty Ltd
No therapeutic indication in the current trial with healthy volunteers.
1 trial -
Evaluation of bioequivalence of two products containing 600 mg ibuprofen: Ibuprofen Sopharma 600 mg film-coated tablets (Test) vs. Brufen 600 mg film-coated tablets (Comparator). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy volunteers
Lacuna Pharma Pty Ltd
No therapeutic indication in the current trial with healthy volunteers.
1 trial -
Evaluation of the Effect of Food, Itraconazole, and Rifampicin on the Single-Dose Pharmacokinetics of Naronapride.
Dr. Falk Pharma GmbH
No medical condition.
1 trial -
Evaluation of the Effect of Itraconazole, Quinidine and Rifampicin on the Single-Dose Pharmacokinetics of ZED1227
Dr. Falk Pharma GmbH
No medical condition.
1 trial -
Evaluation of the bioavailability of two transdermal gel preparations containing 0.1% w/w estradiol under fasting conditions: Estradiol/INTERMED gel 0.1% w/w (Test) vs. ESTREVA® 0.1%, gel (Comparator). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy postmenopausal women
Lacuna Pharma Pty Ltd
No therapeutic indication in the current trial with healthy volunteers.
1 trial -
Evolocumab
BRIGHT MINDS BIOSCIENCES INC.
Healthy Subjects
1 trial -
ExplOratory, Phase 0 Study to assess biodisTribution and PosItron EMission Tomography (PET) Imaging kinetics of [64Cu]Cu-PSMA-R2 in metaStatic prostate cancEr patients
CERO THERAPEUTICS HOLDINGS, INC.
metastatic prostate cancer
1 trial -
Exploratory Bioavailability of Three Formulations of Gliclazide MR Tablets 120 mg (I.R.I.S.) in Healthy Volunteers Under Fed Conditions (High Fat High Calorie Meal and Standard Meal).
The George Institute
No medical condicion.
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources